Stocks and Investing
Stocks and Investing
Wed, November 9, 2022
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
Tue, November 8, 2022
[ Tue, Nov 08th 2022
] - WOPRAI
[ Tue, Nov 08th 2022
] - WOPRAI
[ Tue, Nov 08th 2022
] - WOPRAI
Kristen Kluska Maintained (ABEO) at Buy with Increased Target to $40 on, Nov 8th, 2022
Kristen Kluska of Cantor Fitzgerald, Maintained "Abeona Therapeutics Inc." (ABEO) at Buy with Increased Target from $22 to $40 on, Nov 8th, 2022.
Kristen has made no other calls on ABEO in the last 4 months.
There is 1 other peer that has a rating on ABEO. Out of the 1 peers that are also analyzing ABEO, all agrees with Kristen's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $5 on, Thursday, August 11th, 2022
Contributing Sources